| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1017364 |
Aluminum Sulfate (2 g) |
17927-65-0 |
UN3077 |
| USP-1017502 |
Dried Aluminum Hydroxide Gel (200 mg) |
21645-51-2 |
|
| 2818300000 |
|
|
|
| USP-1018505 |
Amantadine Hydrochloride (200 mg) |
665-66-7 |
UN1759 |
| USP-1018516 |
Amantadine Related Compound A (25 mg) (1-Chloroadamantane) |
935-56-8 |
|
| 2903890002 |
|
|
|
| USP-1018527 |
Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl)acetamide) |
880-52-4 |
|
| 2924299500 |
|
|
|
| USP-1018607 |
Amaranth (50 mg) |
915-67-3 |
|
| 3204120000 |
|
|
|
| USP-1019202 |
Amcinonide (200 mg) |
51022-69-6 |
|
| 2937220000 |
|
|
|
| USP-1019406 |
Amifostine (150 mg) |
112901-68-5 |
|
| 2930909265 |
|
|
|
| USP-1019417 |
Amifostine Disulfide (100 mg) (1,3-Propanediamine, N,N-(dithiodi-2,1-ethanediyl)bis, tetrahydrochloride) |
10027-65-3 |
|
| 2930909265 |
|
|
|
| USP-1019428 |
Amifostine Thiol (50 mg) (2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride) |
14653-77-1 |
|
| 2930909265 |
|
|
|
| USP-1019494 |
Amikacin Sulfate (100 mg) |
39831-55-5 |
|
| 2941906000 |
|
|
|
| USP-1019508 |
Amikacin (300 mg) |
37517-28-5 |
|
| 2941906000 |
|
|
|
| USP-1019701 |
Amiloride Hydrochloride (500 mg) |
17440-83-4 |
UN2811 |
| USP-1019712 |
Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) |
1458-01-1 |
|
| 2933997500 |
|
|
|
| USP-1019756 |
Aminobenzoate Potassium (200 mg) |
138-84-1 |
|
| 2922491000 |
|
|
|
| USP-1019767 |
Aminobenzoate Sodium (200 mg) |
555-06-6 |
|
| 2922491000 |
|
|
|
| USP-1019803 |
Aminobenzoic Acid (200 mg) (p-aminobenzoic acid) |
150-13-0 |
|
| 2922491000 |
|
|
|
| USP-1019870 |
4-Aminobenzoylglutamic Acid (50 mg) |
4271-30-1 |
|
| 2924296000 |
|
|
|
| USP-1020023 |
Gamma-Aminobutyric Acid (50 mg) |
1956/12/2 |
|
| 2922498050 |
|
|
|
| USP-1021000 |
Aminocaproic Acid (200 mg) |
60-32-2 |
|
| 2922498050 |
|
|
|
| USP-1021204 |
4-Aminophenol (100 mg) |
123-30-8 |
UN2512 |
| USP-1021292 |
Aminotriazinone (300 mg) (3-Amino-1,2,4-triazin-5(2H)-one) |
1121-90-0 |
|
| 2933690000 |
|
|
|
| USP-1021703 |
Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) |
63981-22-6 |
|
| 2932190002 |
|
|
|
| USP-1022808 |
2-Amino-5-chlorobenzophenone (25 mg) |
719-59-5 |
|
| 2922390000 |
|
|
|
| USP-1023403 |
Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril) |
5220-02-0 |
|
| 2933790002 |
|
|
|
| USP-1038025 |
Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) |
26953-37-7 |
|
| 2924296000 |
|
|
|
| USP-1040005 |
Antipyrine (200 mg) |
60-80-0 |
|
| 2933110000 |
|
|
|
| USP-1040016 |
Antipyrine Related Compound A (25 mg) (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one) |
89-25-8 |
|
| 2933194350 |
|
|
|
| USP-1040683 |
Apigenin (30 mg) (5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone) |
520-36-5 |
|
| 2932996560 |
|
|
|
| USP-1040708 |
Apigenin-7-glucoside (30 mg) |
578-74-5 |
|
| 2938900000 |
|
|
|
| USP-1041008 |
Apomorphine Hydrochloride (250 mg) |
41372-20-7 |
|
| 2933997000 |
|
|
|
| USP-1041609 |
Apraclonidine Hydrochloride (100 mg) |
73218-79-8 |
UN2811 |
| USP-1041904 |
Aprepitant (150 mg) |
170729-80-3 |
UN3077 |
| USP-1041915 |
Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) |
1148113-53-4 |
|
| 2934990005 |
|
|
|
| USP-1041926 |
Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) |
172822-29-6 |
|
| 2934990005 |
|
|
|
| USP-1041992 |
Desfluoro Aprepitant (15 mg) (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) |
170729-76-7 |
|
| 2934990005 |
|
|
|
| USP-1042055 |
Arabinose (50 mg) |
87-72-9 |
|
| 2940006000 |
|
|
|
| USP-1042102 |
L-Arabinitol (250 mg) |
7643-75-6 |
|
| 2905490000 |
|
|
|
| USP-1042270 |
Arachidyl Alcohol (125 mg) |
629-96-9 |
|
| 2905199095 |
|
|
|
| USP-1154514 |
Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol) |
18029-54-4 |
|
| 2921490002 |
|
|
|
| USP-1154525 |
Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride) |
438-59-5 |
|
| 2921490002 |
|
|
|
| USP-1154558 |
Alpha Cyclodextrin (500 mg) |
10016-20-3 |
|
| 2940006000 |
|
|
|
| USP-1154569 |
Beta Cyclodextrin (500 mg) |
7585-39-9 |
|
| 2940006000 |
|
|
|
| USP-1154591 |
Gamma Cyclodextrin (200 mg) |
17465-86-0 |
|
| 2940006000 |
|
|
|
| USP-1154649 |
Cyclohexanecarboxylic Acid (500 mg) |
98-89-5 |
|
| 2916205000 |
|
|
|
| USP-1156000 |
Cyclopentolate Hydrochloride (300 mg) |
5870-29-1 |
|
| 2922190900 |
|
|
|
| USP-1157002 |
Cyclophosphamide (500 mg) |
6055-19-2 |
|
| 2934990005 |
|
|
|
| USP-1157013 |
Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride) |
821-48-7 |
|
| 2921196190 |
|
|
|
| USP-1157024 |
Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane) |
158401-52-6 |
|
| 2934990005 |
|
|
|
| USP-1157035 |
Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) |
1071-28-9 |
|
| 2921196190 |
|
|
|
| USP-1157046 |
Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride) |
158401-51-5 |
|
| 2921290055 |
|
|
|
| USP-1158005 |
Cycloserine (250 mg) |
68-41-7 |
UN3224 |
| USP-1158504 |
Cyclosporine (50 mg) |
59865-13-3 |
|
| 2933790002 |
|
|
|
| USP-1158650 |
Cyclosporine Resolution Mixture (25 mg) (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1159008 |
Cyclothiazide (200 mg) (AS) |
2259-96-3 |
|
| 2935904000 |
|
|
|
| USP-1161000 |
Cyproheptadine Hydrochloride (500 mg) |
41354-29-4 |
UN2811 |
| USP-1161010 |
Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene) |
256-81-5 |
|
| 2902909500 |
|
|
|
| USP-1161032 |
Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) |
3967-32-6 |
|
| 2914299000 |
|
|
|
| USP-1161203 |
Cyromazine (200 mg) |
66215-27-8 |
|
| 2933690000 |
|
|
|
| USP-1161509 |
L-Cysteine Hydrochloride (600 mg) |
7048/4/6 |
|
| 2930909215 |
|
|
|
| USP-1161586 |
Cystine (200 mg) |
56-89-3 |
|
| 2930904990 |
|
|
|
| USP-1191011 |
Dicyclomine Related Compound A (40 mg) ([1,1′-Bi(cyclohexane)]-1-carboxylic acid) |
60263-54-9 |
|
| 2916205000 |
|
|
|
| USP-1191204 |
Didanosine (200 mg) |
69655-05-6 |
|
| 2934990005 |
|
|
|
| USP-1191215 |
Didanosine System Suitability Mixture (10 mg) |
69655-05-6 |
|
| 3822190000 |
|
|
|
| USP-1191226 |
Didanosine Related Compound A (25 mg) (Hypoxanthine) |
68-94-0 |
|
| 2934990005 |
|
|
|
| USP-1191237 |
Didanosine Related Compound B (25 mg) (2′,3′-dideoxyadenosine) |
4097-22-7 |
|
| 2934990005 |
|
|
|
| USP-1191554 |
Didymin (30 mg) ((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) |
2418540-64-2 |
|
| 2938900000 |
|
|
|
| USP-1213136 |
Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) |
36150-00-2 |
|
| 2937500000 |
|
|
|
| USP-1224959 |
Dolasetron Mesylate (125 mg) |
878143-33-0 |
|
| 2933997500 |
|
|
|
| USP-1224960 |
Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride) |
148091-18-3 |
|
| 2933999552 |
|
|
|
| USP-1224970 |
Donepezil-N-Oxide (20 mg) |
120013-84-5 |
|
| 2933399095 |
|
|
|
| USP-1224981 |
Donepezil Hydrochloride (200 mg) |
884740-09-4 |
UN2811 |
| USP-1224992 |
Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one) |
145546-80-1 |
|
| 2933399095 |
|
|
|
| USP-1225000 |
Doxapram Hydrochloride (200 mg) |
7081-53-0 |
UN2811 |
| USP-1225022 |
Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride) |
100106-91-0 |
|
| 2933999552 |
|
|
|
| USP-1231626 |
Ecamsule Related Compound B (50 mg) (4-(Hydroxymethyl)benzoic acid) |
3006-96-0 |
|
| 2918195000 |
|
|
|
| USP-1231637 |
Ecamsule Related Compound C (50 mg) (terephthalic acid) |
100-21-0 |
|
| 2917360000 |
|
|
|
| USP-1231648 |
Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid) |
5872/8/2 |
UN3261 |
| USP-1231659 |
Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) |
N/A |
|
| 2914710000 |
|
|
|
| USP-1231660 |
Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid) |
N/A |
|
| 2918300000 |
|
|
|
| USP-1231681 |
Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt) |
N/A |
|
| 2914710000 |
|
|
|
| USP-1231706 |
Powdered Echinacea Angustifolia Extract (1 g) |
84696-11-7 |
|
| 1302190200 |
|
|
|
| USP-1231717 |
Powdered Echinacea Pallida Extract (1 g) |
97281-15-7 |
|
| 1302190200 |
|
|
|
| USP-1231728 |
Powdered Echinacea Purpurea Extract (1 g) |
90028-20-9 |
|
| 1302190200 |
|
|
|
| USP-1231750 |
Echinacoside (15 mg) |
82854-37-3 |
|
| 2938900000 |
|
|
|
| USP-1231808 |
Econazole Nitrate (250 mg) |
24169-02-6 |
|
| 2933290000 |
|
|
|
| USP-1231830 |
Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol) |
24155-42-8 |
|
| 2933290000 |
|
|
|
| USP-1231852 |
Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) |
N/A |
|
| 2933290000 |
|
|
|
| USP-1232006 |
Edetate Calcium Disodium (200 mg) |
6766-87-6 |
|
| 2922498050 |
|
|
|
| USP-1233009 |
Edetate Disodium (200 mg) |
6381-92-6 |
|
| 2922498050 |
|
|
|
| USP-1233508 |
Edetic Acid (200 mg) |
60-00-4 |
|
| 2922498050 |
|
|
|
| USP-1234001 |
Edrophonium Chloride (200 mg) |
116-38-1 |
|
| 2923900100 |
|
|
|
| USP-1302178 |
Guarana Seed Dry Extract (1 g) |
NA |
|
| 1302190200 |
|
|
|
| USP-1302203 |
Purified Guggul Extract (500 mg) |
N/A |
|
| 1301900190 |
|
|
|
| USP-1302214 |
Guggulsterone Z (25 mg) |
39025-23-5 |
|
| 2914299000 |
|
|
|
| USP-1302247 |
Gymnemagenin (15 mg) |
22467-07-8 |
|
| 2906195000 |
|
|
|
| USP-1302258 |
Native Gymnema Extract (1 g) |
90045-47-9 |
|
| 1302190200 |
|
|
|
| USP-1302509 |
Halcinonide (200 mg) |
3093-35-4 |
|
| 2937220000 |
|
|
|
| USP-1302906 |
Halobetasol Propionate (200 mg) |
66852-54-8 |
|
| 2937220000 |
|
|
|
| USP-1303002 |
Haloperidol (200 mg) |
52-86-8 |
UN2811 |
| USP-1303013 |
Haloperidol Related Compound A (10 mg) (4,4′-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophenone) |
67987-08-0 |
|
| 2933399095 |
|
|
|
| USP-1303024 |
Haloperidol Related Compound B (10 mg) (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one) |
1391052-53-1 |
|
| 2933399095 |
|
|
|
| USP-1303057 |
Haloperidol Decanoate (200 mg (需冷链运输) |
74050-97-8 |
|
| 2933399095 |
|
|
|
| USP-1336205 |
Ifosfamide (500 mg) |
3778-73-2 |
UN2811 |
| USP-1336249 |
Iloperidone (200 mg) |
133454-47-4 |
|
| 2934990005 |
|
|
|
| USP-1336250 |
Iloperidone Related Compound A (20 mg) ([4′-(3-Chloropropoxy)-3′-methoxy]acetophenone) |
58113-30-7 |
|
| 2914710000 |
|
|
|
| USP-1336500 |
Imidazole (200 mg) (1H-Imidazole) |
288-32-4 |
UN2923 |
| USP-1336806 |
Imidurea (200 mg) |
39236-46-9 |
|
| 2933210000 |
|
|
|
| USP-1337004 |
Iminodibenzyl (25 mg) (10,11-Dihydro-5H-dibenzo[b,f]azepine) |
494-19-9 |
|
| 2933991200 |
|
|
|
| USP-1337809 |
Imipenem Monohydrate (100 mg) |
74431-23-5 |
|
| 2941906000 |
|
|
|
| USP-1338007 |
Imipramine Hydrochloride (200 mg) |
113-52-0 |
|
| 2933995800 |
|
|
|
| USP-1338313 |
Imiquimod (200 mg) |
99011-02-6 |
|
| 2933997000 |
|
|
|
| USP-1338324 |
Imiquimod Related Compound A (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline) |
99010-24-9 |
|
| 2933998350 |
|
|
|
| USP-1338335 |
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) |
99010-63-6 |
|
| 2933998350 |
|
|
|
| USP-1338346 |
Imiquimod Related Compound C (25 mg) (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline) |
99010-64-7 |
|
| 2934990005 |
|
|
|
| USP-1338357 |
Imiquimod Related Compound D (25 mg) (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine) |
853792-81-1 |
|
| 2933998350 |
|
|
|
| USP-1338481 |
Imipramine Pamoate (300 mg) |
10075-24-8 |
|
| 2933996100 |
|
|
|
| USP-1338801 |
Indapamide (500 mg) |
26807-65-8 |
|
| 2935904000 |
|
|
|
| USP-1338812 |
Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide) |
63968-75-2 |
|
| 2935909550 |
|
|
|
| USP-1339000 |
Indigotindisulfonate Sodium (750 mg) |
860-22-0 |
|
| 3204120000 |
|
|
|
| USP-1339178 |
Indinavir (100 mg) |
180683-37-8 |
|
| 2933595960 |
|
|
|
| USP-1339189 |
Indinavir System Suitability (100 mg) |
180683-37-8 |
|
| 2933595960 |
|
|
|
| USP-1340009 |
Indocyanine Green (250 mg) |
3599-32-4 |
|
| 2933998350 |
|
|
|
| USP-1617430 |
Sotalol Related Compound C (50 mg) (N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) |
16974-42-8 |
|
| 2935909550 |
|
|
|
| USP-1617474 |
Defatted Powdered Soy (2.5 g) |
68513-95-1 |
|
| 3504001090 |
|
|
|
| USP-1618003 |
Spectinomycin Hydrochloride (200 mg) |
22189-32-8 |
|
| 2941906000 |
|
|
|
| USP-1618717 |
Spinosin (15 mg) |
72063-39-9 |
|
| 2938900000 |
|
|
|
| USP-1619006 |
Spironolactone (125 mg) |
1952/1/7 |
|
| 2937290000 |
|
|
|
| USP-1619017 |
Spironolactone Related Compound A (100 mg) ((2’R)-3′,4′-Dihydro-5’H-spiro[androst-4,6-diene-17,2′-furan]-3,5′-dione) |
976-71-6 |
|
| 2937290000 |
|
|
|
| USP-1619028 |
Spironolactone Related Compound B (30 mg) ((2’R)-7alpha-(Acetylthio)-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) |
132458-33-4 |
|
| 2937290000 |
|
|
|
| USP-1619039 |
Spironolactone Related Compound C (30 mg) ((2’R)-3′,4′-Dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) |
976-70-5 |
|
| 2932206000 |
|
|
|
| USP-1619040 |
Spironolactone Related Compound D (30 mg) ((2’R)-7alpha-(Acetyldisulfanyl)-3′,4′-dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) |
N/A |
|
| 2937290000 |
|
|
|
| USP-1619051 |
Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture) |
N/A |
|
| 2932206000 |
|
|
|
| USP-1619094 |
Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate) |
N/A |
|
| 2937290000 |
|
|
|
| USP-1620209 |
Stavudine (250 mg) |
3056-17-5 |
|
| 2934990005 |
|
|
|
| USP-1620220 |
Stavudine System Suitability Mixture (10 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1621008 |
Stearic Acid (500 mg) |
1957/11/4 |
|
| 2915700100 |
|
|
|
| USP-1621507 |
Stearoyl Polyoxylglycerides (100 mg) |
9011-21-6 |
|
| 3824994100 |
|
|
|
| USP-1622000 |
Stearyl Alcohol (125 mg) |
112-92-5 |
|
| 2905170000 |
|
|
|
| USP-1622044 |
Stearylpyridinium Chloride (25 mg) (1-Octadecylpyridinium chloride) |
3165-81-9 |
UN2811 |
| USP-1622317 |
Steviol Glycosides System Suitability (50 mg) |
91722-21-3 |
|
| 2938900000 |
|
|
|
| USP-1622408 |
Stevioside (30 mg) |
57817-89-7 |
|
| 2938900000 |
|
|
|
| USP-1623003 |
Streptomycin Sulfate (200 mg) |
3810-74-0 |
|
| 2941205000 |
|
|
|
| USP-1623386 |
Compressible Sugar (200 mg) |
N/A |
|
| 1701994000 |
|
|
|
